Deep frozen solutions are suitable for short-term vaccine storage
Peli BioThermal has announced deep frozen temperature controlled packaging options with temperature ranges of -80°C to -20°C. The offerings help meet the growing need for increased deep frozen temperature ranges and payload capacities as pharmaceutical companies and their supply chains prepare to bring COVID-19 vaccines and therapeutics to market.
Peli BioThermal has long offered its reusable Crēdo Cube in -20 °C and -50 °C Celsius temperatures. Many of the company’s product lines now include a variety of frozen options that cover temperatures of -20, -35, -50 and -80 ° Celsius.
Product lines that offer deep frozen options include Crēdo Cube, CoolGuard Advance, CoolPal Flex, Sherpa Systems™, Crēdo Xtreme and Crēdo Cargo shippers. These lines include parcel and pallet sizes, as well as offering both single use and reusable temperature controlled shippers. Many of these expanded temperature ranges are also available through the Crēdo on Demand rental program.
“We know that pharmaceutical companies are in all phases of the development process for vaccines and therapeutics and working tirelessly to bring safe and effective drug products to market quickly,” said Greg Wheatley, Vice President of Worldwide New Product Development and Engineering at Peli BioThermal. “Our engineering team matched this urgency to ensure they have the correct temperature controlled packaging to meet them where they’re at in drug development for the pandemic recovery, from discovery to distribution.”
Peli’s products use phase change material (PCM) and dry ice systems to provide frozen payload protection with durations from 72 to 144 hours. Payload capacities range from 1 to 96 litres for parcel shippers and 371 to 1,686 litres for pallet shippers.
Deep frozen solutions are suitable for short-term vaccine storage, redirect courier transport of vaccines from freezer farm hubs to immunisation locations and daily vaccine replenishment to remote and rural areas.